UNC awarded Cancer Genome Atlas grant

September 30, 2009

CHAPEL HILL, N.C. - The University of North Carolina at Chapel Hill is one of twelve centers announced today by President Obama as part of an unprecedented large-scale, collaborative effort by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer.

The Cancer Genome Atlas Grant (TCGA) is a five-year award, expected to bring $13 to $20 million to UNC, which puts scientists from the university's Lineberger Comprehensive Cancer Center and their collaborators across campus at the center of a major push to provide a deeper, more systematic understanding of the mechanisms responsible for the uncontrolled growth of cancer cells and their spread throughout the body.

According to the NHGRI, the genomic information generated by the project could fuel rapid advances in cancer research including new ways to categorize tumors, new therapeutic targets, and methods that allow clinical trials to focus on patients who are most likely to respond to specific treatments. The project aims to develop a comprehensive catalog of the many genetic and genomic changes that occur in cancers including chromosomal changes, gene expression differences, DNA mutations, and epigenomic changes (changes that happen to DNA but do not change the underlying hereditary information).

"This project represents one of the most ambitious and challenging human genetics efforts to date, only rivaled by its predecessor, the Human Genome Project," said Dr. Charles Perou, associate professor of genetics, and pathology & laboratory medicine.

"The TCGA project takes a comprehensive approach to the study of human cancers and applies multiple cutting-edge technologies to the same large set of tumors. The real power of this project is in the integration of these different genetic data types into a common framework that should provide a much more complete picture of why a tumor is a tumor," he added.

"We are enormously excited to be one of only a handful of institutions selected for this tremendously important cancer project," said Dr. H. Shelton Earp, Director of UNC Lineberger Comprehensive Cancer Center.

"Cancer genetics has been a key area for University Cancer Research investment, allowing us to diversify the technologic base needed for this project. This phase of The Cancer Genome Atlas will yield many new cancer discoveries that may change the face of clinical cancer care in the near future."

UNC's specific focus is to characterize what genes are being expressed, and not expressed, in each tumor type studied. Using a methodology called "gene expression profiling", scientists get a very powerful look at a given tumor and can precisely determine what genes are "on" and what genes are "off". Cancers are typically caused by some genes being inappropriately on, and other genes being inappropriately off, thus being able to look at all genes at once and determine which are on is critical to a better understanding of tumor biology.

Project co-director Neil Hayes, notes that the laboratory science is specifically designed to benefit patients as quickly as possible. "Our participation is recognition that UNC has a community of cutting-edge researchers, particularly in our 'bench to bedside' approach and as one of only a few NCI-designated Comprehensive Cancer Centers included in the funding. Just as we balance our days between patient care and science, the leadership at NCI and NHGRI is asking us to keep this project grounded in benefits to patients. I can't imagine a more important leadership role, and we take this charge very seriously," he said.
-end-
The UNC project team is headed by Drs. Charles Perou and Neil Hayes and includes a broad multi-disciplinary team that reflects the tremendous complexity and depth of the data collected, and the desire to extract as many biological insights out of this data as possible. Team members hail from seven different departments across UNC-Chapel Hill including Genetics (Drs. Derek Chiang and Piotr Mieczkowski), Medicine (Dr. Neil Hayes), Biology (Drs. Jason Lieb and Corbin Jones), Pathology (Drs. Charles Perou and Michael Topal), Statistics (Drs. Steve Marron and Andrew Nobel), and Biostatistics (Drs. Yufeng Li, Wei Sun and Fred Wright).

University of North Carolina Health Care

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.